All Reports Events Blogs Videos
Showing 66 results
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • LinkedIn Live
    July 24, 2025

    Watch on LinkedIn Global Capability Centers (GCCs) in India rapidly evolved from cost-efficient service hubs to strategic centers of innovation, product development, and digital transformation for global enterprises. As this evolution accelerated, talent development became a…
  • PEAK Matrix®
    June 09, 2025

    The life sciences industry is undergoing rapid digital transformation, fueled by the need for greater agility, regulatory compliance, and patient-centric operations. Enterprise platforms such as SAP, Oracle, and Salesforce have evolved from back-end systems of record…
  • State of the Market
    May 07, 2025

    The life sciences R&D engine is rapidly digitizing, and clinical development software now sits at its center. This report sizes the global clinical trials technology market at nearly US$6.5 billion for 2025 (8-10% CAGR) and dissects…
  • LinkedIn Live
    Feb. 13, 2025

    Watch On LinkedIn Step into the future in this insightful LinkedIn Live with Everest Group experts Hrishi Raj Agarwalla, Vice President, and Ashish Sehdev, Vice President. Join this virtual session as they decode the market shifts…
  • Feb. 03, 2025

    The nasscom GCC Conclave 2025 nominations period is nearly here! Opening on Feb 4, 2025, the nominations will open for GCC leaders to put their businesses forward for recognition. Supported by Strategic Partner Everest Group, the…
  • Viewpoint
    Dec. 06, 2024

    The Indian Banking, Financial Services, and Insurance (BFSI) sector is rapidly evolving, driven by innovation and regulatory compliance. This viewpoint examines key technology trends reshaping the industry, including AI, cloud computing, blockchain, and automation, which are…
  • PEAK Matrix®
    Nov. 11, 2024

    Clinical Trial Management Systems (CTMS) are vital to modern clinical research, offering essential tools to manage and track all operational aspects of the trial process. Clinical trials’ increasing complexity, the growing data volume, and the need…
  • Market Insights™
    Oct. 16, 2024

  • Market Insights™
    Sep. 26, 2024

  • Market Insights™
    Sep. 26, 2024

  • Thematic Report
    Sep. 23, 2024

    In the dynamic life sciences clinical development field, patient engagement has emerged a vital innovation and success driver. As clinical research evolves, integrating patient perspectives and active participation has become a transformative force, significantly enhancing clinical…
  • LinkedIn Live
    Sep. 11, 2024

    How can you best put generative AI to work for your business, and what are the real-world applications for this emerging technology ? Join Everest Group experts Suseel Menon, Practice Director, and Ashish Sehdev, Vice President,…
  • Viewpoint
    Sep. 05, 2024

    Drug development is a complex, time-consuming, and expensive process. The average cost to develop a new drug has increased from US$1.3 million in 2013 to US$2.3 billion in 2022. This cost increase poses a significant challenge…
  • Event
    Aug. 29, 2024

    Everest Group is a sponsoring partner for the Spotlight AR Summit on September 30 – October 2, 2024 at the Loews Hotel, Kansas City. Join Everest Group’s Katrina Menzigian, Vice President, Abhishek Singh, Partner, and Chirajeet…
  • Viewpoint
    July 03, 2024

    Gen AI can create diverse content and data formats, revolutionizing the AI landscape and transforming businesses. The pharmaceutical industry can use gen AI to sift through vast clinical data volumes, enabling trial protocols’ drafting and improving clinical…
  • LinkedIn Live
    June 05, 2024

    To meet evolving customer expectations, businesses are seeking to develop artificial intelligence (AI) tools to enhance their customer experiences. From personalizing experiences to providing in-depth analytics, the potential for AI to transform CX and its management…

Items per page